ask="12.2000"
ask_size="100"
average_daily_volume="26565"
bid="11.6400"
bid_size="500"
book_value="3.3400"
change="+0.7100"
change_from_200_day_moving_average="4.6717"
change_from_50_day_moving_average="2.5853"
change_from_52_week_high="-0.3419"
change_From_52_week_low="7.9699"
change_in_percent="+6.5863%"
close="11.4899"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.2620"
ebitda="-50.28M"
eps_estimate_current_year="-2.5400"
eps_estimate_next_quarter="-0.6000"
eps_estimate_next_year="-2.5700"
ex_dividend_date="N/A"
float_shares="N/A"
high="11.8318"
high_52_weeks="11.8318"
last_trade_date="3/1/2017"
last_trade_price="11.4899"
last_trade_size="2000"
last_trade_time="3:59pm"
low="10.5100"
low_52_weeks="3.5200"
market_capitalization="244.51M"
moving_average_200_day="6.8182"
moving_average_50_day="8.9046"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.8100"
open="10.7500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+68.5186%"
percent_change_from_50_day_moving_average="+29.0339%"
percent_change_from_52_week_high="-2.8897%"
percent_change_from_52_week_low="+226.4176%"
previous_close="10.7799"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.2275"
price_per_sales="44.1137"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.7900"
stock_exchange="NMS"
symbol="NBRV"
volume="142547"
weeks_range_52="3.5200 - 11.8318"
